<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01997580</url>
  </required_header>
  <id_info>
    <org_study_id>A121987</org_study_id>
    <nct_id>NCT01997580</nct_id>
  </id_info>
  <brief_title>Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder</brief_title>
  <official_title>Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health &amp; Welfare, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore electrophysiologic parameters and biomarkers predicting treatment response of
      patients with major depressive disorder To explore electrophysiologic parameters and
      biomarkers predicting suicide risk of patients with major depressive disorder
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Case-control study Repeated measures design
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in baseline frequency of maximum of cross-spectrum during 6 weeks (Hz)</measure>
    <time_frame>0, 3, 7, 14, and 42 days</time_frame>
    <description>the link between the normalized high frequency component of heart rate variability (HRV-HFnu) representing cardiac vagal modulation and frontal alpha power related to resting state</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cardiorespiratory coupling during 6 weeks</measure>
    <time_frame>0, 3, 7, 14, and 42 days</time_frame>
    <description>change in value of cross-sample entropy measured by combining sample entropies of heart rate and respiration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HF during 6 weeks</measure>
    <time_frame>0, 3, 7, 14, and 42 days</time_frame>
    <description>change in high frequency component of heart rate variability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in persistent homology during 6 weeks</measure>
    <time_frame>0, 3, 7, 14, and 42 days</time_frame>
    <description>change in disconnection pattern of EEG channel activities measured by Euclidean distance during 6 weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Escitalopram</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>depressed patients receiving escitalopram treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>healthy controls matched for age, gender, and BMI</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>escitalopram</intervention_name>
    <description>SSRI antidepressant</description>
    <arm_group_label>Escitalopram</arm_group_label>
    <other_name>lexapro</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-IV-TR major depressive disorder

          -  aged between 20 and 80

          -  durg-naive or drug-free

        Exclusion Criteria:

          -  DSM-IV-TR substance-related disorders (except nicotine)

          -  significant medical or neurological conditions

          -  mental retardation or organic brain damage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae Seung Chang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae Seung Chang, MD, PhD</last_name>
    <phone>82-31-787-7437</phone>
    <email>cjs0107@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Seung Chang, MD, PhD</last_name>
      <phone>82-31-787-7437</phone>
      <email>cjs0107@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Meerae Lim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.nlm.nih.gov/medlineplus/ency/article/000945.htm</url>
    <description>health information about depression</description>
  </link>
  <reference>
    <citation>Chang JS, Yoo CS, Yi SH, Her JY, Choi HM, Ha TH, Park T, Ha K. An integrative assessment of the psychophysiologic alterations in young women with recurrent major depressive disorder. Psychosom Med. 2012 Jun;74(5):495-500. doi: 10.1097/PSY.0b013e31824d0da0. Epub 2012 Mar 9.</citation>
    <PMID>22408133</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2013</study_first_submitted>
  <study_first_submitted_qc>November 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <last_update_submitted>November 22, 2013</last_update_submitted>
  <last_update_submitted_qc>November 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Jae Seung Chang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>depression</keyword>
  <keyword>treatment</keyword>
  <keyword>electrophysiology</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Dexetimide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

